X4 Pharmaceuticals Inc (NAS:XFOR)
$ 0.393 0.0036 (0.92%) Market Cap: 67.03 Mil Enterprise Value: 10.25 Mil PE Ratio: 0 PB Ratio: 1.11 GF Score: 30/100

Q3 2020 X4 Pharmaceuticals Inc Earnings Call Transcript

Nov 05, 2020 / 01:30PM GMT
Release Date Price: $6.01 (-6.68%)
Operator

Greetings and welcome to X4 Pharmaceuticals Third-Quarter Financial and Operating Results Conference Call. (Operator Instructions) As a reminder this conference call is being recorded. It is now my pleasure to introduce your host, Candice Ellis, director of Corporate Communications and Investment Relations at X4. You may begin.

Candice Ellis
X4 Pharmaceuticals - Director, Corporate Communications & Investor Relations

Thank you, Operator. And good morning everyone. Thanks so much for joining us today. Presenting on today's call, we have our Chief Executive Officer, Dr. Paula Ragan, and our Chief Financial Officer, Adam Mostafa.

Following prepared remarks by each, we'll open the call to your questions. And they'll be joined by our Senior Vice President of Technical Operations and Quality, Dr. Mary DiBiase.

As a reminder on today's call, we'll be making forward-looking statements regarding our regulatory and product development plans, as well as our research activities.

These statements are subjected to risks and uncertainties

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot